News FDA eyes shake-up of swift approval pathway in cancer Regulator wants more use of randomised controlled trials rather than open-label studies.
News Novartis pulls plug on landmark UK cholesterol trial ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.
News MHRA unveils big shakeup in UK clinical trials regs Reforms will make applications streamlined and flexible without affecting safety, says agency.
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
Oncology Better balance of cancer treatment efficacy and toxicity The FDA Oncology Center of Excellence announced its Project Optimus draft guidance in January.
News FDA eyes shake-up of swift approval pathway in cancer Regulator wants more use of randomised controlled trials rather than open-label studies.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
